image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 10 days, don't miss out!

Playtech - Huge gaming opportunity in Americas

May 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PTEC
  • Price:
  • 550p
Gambling operators such as Entain, 1302p (which owns Ladbrokes, Coral and Sportingbet) and Flutter, 15055p (Paddy Power, Fanduel) are betting the house on the extraordinary growth in US regulated online gaming, which grew 61% to an estimated US$12.2 billion in 2022 including US$6.9 bn in sports betting and US$5.5bn in igaming (casinos, slots, bingo etc.). With US states eyeing up the tax revenue opportunities, this market is forecast to reach US$23 bn in 2026 with sports betting seeing the fastest growth at 20%. There’s also a less heralded but equally exciting opportunity in South  America where Mexico (population: 129 billion), Columbia and Argentina are thriving markets, while Brazil, the most populous (213 bn) with a GDP equiv ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author